CX 2017 Presentations
Please note: Some presentations may not be available as permission may not have been given.
CX ilegx Interdisciplinary Consensus on Severe Ischaemia - Thursday, 27th April
Venue: Lower Main Auditorium
Whether to intervene
Time: 08:00 - 10:00
| Chairing: | Michael Jaff, Boston, United States |
| Moderator: | Cliff Shearman, Southampton, United Kingdom |
Time: 08:00 - 08:08
Algorithm of care: how has evidence changed my current treatment practices
| Speaker: | Fabrizio Fanelli, Florence, Italy |
Time: 08:08 - 08:16
Endovascular therapy for chronic limb ischaemia - when is enough enough?
| Speaker: | Barry Katzen, Miami, United States |
Time: 08:26 - 08:34
Toe pressure is a better indicator of peripheral arterial disease and cardiovascular risk than the ankle branchial index
| Speaker: | Mirjami Laivuori, Helsinki, Finland |
Time: 08:34 - 08:42
Fusion imaging reduces the need for contralateral or brachial access when using re-entry catheters to cross total aorto-iliac artery occlusions
| Speaker: | Klaus Overbeck, Sunderland, United Kingdom |
Time: 08:52 - 09:00
A new classification system for femoropopliteal artery patterns of restenosis: introduction and application
| Speaker: | Lawrence Garcia, Boston, United States |
Time: 09:00 - 09:08
Cost vs. benefit - does the use of an aggressive endovascular solution for the individual patient benefit the greater community?
| Speaker: | Ian Spark, Kingswood, Australia |
Time: 09:18 - 09:26
The clear need for improved diagnostics in the diagnosis of peripheral arterial disease in UK general practice
| Speaker: | Daniel Kyle, Sunderland, United Kingdom |
Time: 09:26 - 09:34
Comorbidities, amputation rates and mortality in patients revascularized for intermittent claudication and critical limb ischaemia: a population based study
| Speaker: | Erik Baubeta Fridh, Jönköping, Sweden |
Time: 09:34 - 09:42
Arterial ulceration - core team and outreach provision
| Speaker: | Dean Williams, Bangor, United Kingdom |
Time: 09:42 - 10:00
Roundtable: whether to intervene and its value
| Chairing: | Michael Jaff, Boston, United States |
| Panel: | Cliff Shearman, Southampton, United Kingdom |
COFFEE
Time: 10:00 - 10:30
Diabetic and critical limb ischaemia patients
Time: 10:30 - 12:30
| Chairing: | Michael Edmonds, London, United Kingdom |
| Moderators: | Iris Baumgartner, Bern, Switzerland |
| Thomas Zeller, Bad Krozingen, Germany |
Time: 10:30 - 10:38
Endpoint definitions in clinical trials: are they assessed the same way and why it matters
| Speaker: | Michael Jaff, Boston, United States |
Time: 10:38 - 10:46
Importance of independent adjudication and corelab assessment in superficial femoral artery studies
| Speaker: | William Gray, Wynnewood, United States |
Time: 10:46 - 10:54
Exercise and exercise devices in the diabetic population update
| Speaker: | Nicola Troisi, Florence, Italy |
Time: 10:54 - 11:04
Glycaemic control in the patient with diabetes undergoing revascularisation?
| Speaker: | Ketan Dhatariya, Norwich, United Kingdom |
Time: 11:14 - 11:22
Amputation rates and risk factors for amputations in people with diabetes in United Kingdom
| Speaker: | Robert Hinchliffe, Bristol, United Kingdom |
Time: 11:22 - 11:30
Multiple interventions for diabetic foot ulcer treatment (MIDFUT) trial
| Speaker: | David Russell, Leeds, United Kingdom |
Time: 11:30 - 11:38
The importance of the angiosome theory: what is the difference between endovascular and surgical bypass?
| Speaker: | Maarit Venermo, Helsinki, Finland |
Time: 11:38 - 11:46
Treatment of the infected foot
| Speaker: | Patrick F.S. Chong, Frimley, United Kingdom |
Time: 11:56 - 12:04
Cell therapies in non-reconstructable critical limb ischaemia - what is their role?
| Speaker: | Gerry Stansby, Newcastle-upon-Tyne, United Kingdom |
Time: 12:04 - 12:12
Drug-coated balloon evidence in diabetics and females
| Speaker: | Gunnar Tepe, Rosenheim, Germany |
Time: 12:12 - 12:20
The use of dermal skin substitutes to aid healing
| Speaker: | David Russell, Leeds, United Kingdom |
Lunch
Time: 12:30 - 13:30
Drug-coated balloons
Time: 13:30 - 14:46
| Chairing: | TBA |
| Moderator: | TBA |
Time: 13:30 - 13:38
Drug-coated balloon level one evidence review of four DCB pivotal randomised controlled trials
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
Time: 13:38 - 13:46
Drug-coated balloon in the treatment of popliteal artery
| Speaker: | Koen Deloose, Dendermonde, Belgium |
Time: 13:46 - 13:54
IN.PACT Japan randomised controlled trial
| Speaker: | Osamu Iida, Amagasaki, Japan |
Time: 13:54 - 14:02
Vessel wall aspects - stability of coating
| Speaker: | Peter Goverde, Antwerp, Belgium |
Time: 14:12 - 14:20
Optical coherence tomography with debulking and drug-coated balloon
| Speaker: | Marianne Brodmann, Graz, Austria |
Time: 14:20 - 14:28
Interim results of the Lutonix SFA Long Lesion Study
| Speaker: | Dierk Scheinert, Leipzig, Germany |
Time: 14:28 - 14:36
CONSEQUENT DCB 12-month results
| Speaker: | Gunnar Tepe, Rosenheim, Germany |
Below the knee
Time: 14:46 - 15:30
| Chairing: | TBA |
| Moderator: | TBA |
Time: 14:46 - 14:54
New generation for the treatment of femoral and below the knee lesions
| Speaker: | Eugenio Stabile, Salerno, Italy |
Time: 14:54 - 15:02
Interim results of the Lutonix DCB Global Real World BTK registry - six month outcomes
| Speaker: | Dierk Scheinert, Leipzig, Germany |
Time: 15:02 - 15:10
The future of the bioresorbable scaffold for drug elution
| Speaker: | Ramon Varcoe, Randwick, Australia |
Time: 15:20 - 15:30
Roundtable - What have we learned about DCB at CX 2017
| Chairing: | Roger Greenhalgh, London, United Kingdom |
| Panel: | Michael Jaff, Boston, United States |
| Ian Spark, Kingswood, Australia | |
| Charles McCollum, Manchester, United Kingdom |
Coffee
Time: 15:30 - 16:00
Stents
Time: 16:00 - 18:00
| Chairing: | Thomas Zeller, Bad Krozingen, Germany |
| Moderator: | Trevor Cleveland, Sheffield, United Kingdom |
Time: 16:00 - 16:06
Durability of stent grafts for long lesions
| Speaker: | Osamu Iida, Amagasaki, Japan |
Time: 16:06 - 16:12
Preliminary results of an Italian multicentre registry using Tigris
| Speaker: | Maria Antonella Ruffino, Turin, Italy |
Time: 16:12 - 16:18
LOCOMOTIVE study: multistent use for long SFA lesions
| Speaker: | Klaus Amendt, Mannheim, Germany |
Time: 16:18 - 16:24
Beyond bare metal: precise and durable outcomes with the Gore Tigris Vascular Stent
| Speaker: | TBA |
Time: 16:32 - 16:38
Value of interwoven nitinol stent in non-fempop territories
| Speaker: | Rajiv Parakh, Gurgaon, India |
Time: 16:38 - 16:44
How the unique features of the vascular stent relate to optimal clinical outcomes
| Speaker: | Martin Werner, Vienna, Austria |
Time: 16:44 - 16:52
The benefits of IVUS in peripheral intervention
| Speaker: | Ian Spark, Kingswood, Australia |
Time: 16:52 - 17:02
Audience participation and stent round table discussion - What we learnt on stents at CX 2017
| Chairing: | Roger Greenhalgh, London, United Kingdom |
| Panel: | Trevor Cleveland, Sheffield, United Kingdom |
| Thomas Zeller, Bad Krozingen, Germany |
Stent grafts and in-stent restenosis
Time: 17:02 - 17:32
Time: 17:02 - 17:08
Select 12-month results from the first and only randomised in-stent restenosis (ISR) study with drug-coated balloon
| Speaker: | Koen Deloose, Dendermonde, Belgium |
Time: 17:08 - 17:14
RAPID trial: drug-coated balloon and stent
| Speaker: | Jean-Paul de Vries, Groningen, Netherlands |
Time: 17:14 - 17:20
In-stent restenosis treated by stent graft
| Speaker: | Gunnar Tepe, Rosenheim, Germany |
Bypass has a place
Time: 17:32 - 18:00
Time: 17:32 - 17:38
Follow-up of patients treated by prosthetic bypass of the lower limb: a cost model evaluation at two years
| Speaker: | Yann Goueffic, Nantes, France |
Time: 17:38 - 17:44
Not always endovascular first - the BEST trial
| Speaker: | Matthew Menard, Boston, United States |
Time: 17:44 - 17:50
BASIL 2 & 3
| Speaker: | Andrew Bradbury, Birmingham, United Kingdom |
Time: 17:50 - 18:00
Roundtable - what we learned of the place of stent, stent graft & open bypass at CX 2017
| Chairing: | Roger Greenhalgh, London, United Kingdom |
| Moderators: | Thomas Zeller, Bad Krozingen, Germany |
| Trevor Cleveland, Sheffield, United Kingdom | |
| Yann Goueffic, Nantes, France |